|
Page
Updated - 4-1-2007
|
|
Alzheimer's DiseaseAlzheimer's & Turmeric (Curry Spice) Parkinsonson Disease and CoQ10
Get Free Information about Herb, Vitamin and Drug InteractionsHealth Notes is the leading provider of science-based information on healthy living. Gathered from scientific studies published in over 550 peer-reviewed medical and scientific journals. Visit Health Notes for drug interactions
|
Turmeric Curry may keep Alzheimer's at bayLOS ANGELES, Dec 29, 2004 (United Press International via COMTEX) -- A spice used for thousands of years, curry, may be a powerful new weapon in fighting Alzheimer's Disease, researchers said. Researchers from UCLA and the Department of Veterans Affairs said their study of curcumin, the yellow pigment in curry, found it broke up existing beta amyloid on rats' brains and helped prevent accumulation of the destructive plaque. Reporting
in the Journal of Biological Chemistry, the team said curcumin is more
effective in stopping the protein fragments from forming than many other
drugs being tested to treat the disease that affects 4 million Americans
and millions more worldwide. "Curcumin has been used for thousands of years as a safe anti-inflammatory in a variety of ailments as part of Indian traditional medicine," Cole said. Recent animal studies "support a growing interest in its possible use for diseases of aging involving oxidative damage and inflammation like Alzheimer's, cancer and heart disease." Cole called for human trials of curcumin to establish safe and effective doses. Curcumin inhibits formation of Abeta oligomers and fibrils and binds plaques and reduces amyloid in vivo.By GRECC (VA Medical) and Medicine, University of California Los Angeles Alzheimer's disease involves amyloid (Abeta) accumulation, oxidative damage and inflammation, and risk is reduced with increased antioxidant and anti-inflammatory consumption. The phenolic yellow curry pigment curcumin has potent anti-inflammatory and antioxidant activities and can suppress oxidative damage, inflammation, cognitive deficits, and amyloid accumulation. Since the molecular structure of curcumin suggested potential Ass-binding, we investigated whether its efficacy in Alzheimer's disease models could be explained by effects on Ass aggregation. Under aggregating conditions in vitro, curcumin inhibited aggregation (IC(50) =0.8 microM) as well as disaggregated fibrillar Ass40 (IC(50) =1 microM), indicating favorable stoichiometry for inhibition. Curcumin was a better Abeta40 aggregation inhibitor than ibuprofen and naproxen, and prevented Abeta42 oligomer formation and toxicity between 0.1-1.0 muM. Under electron microscopy, curcumin decreased dose-dependently Ass fibril formation beginning with 0.125 microM. Curcumin's effects did not depend on Abeta sequence but on fibril-related conformation. Alzheimer's disease and Tg2576 mice brain sections incubated with curcumin revealed preferential labeling of amyloid plaques. In vivo studies showed that curcumin injected peripherally into aged Tg mice, crossed the blood brain barrier and bound plaques. When fed to aged Tg2576 mice with advanced amyloid accumulation, curcumin labeled plaques and reduced amyloid levels and plaque burden. Hence, curcumin directly binds small ss-amyloid species to block aggregation and fibril formation in vitro and in vivo. These data suggest that low dose curcumin effectively disaggregates Ass as well as prevents fibril and oligomer formation, supporting the rationale for curcumin use in clinical trials preventing or treating Alzheimer's disease. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM. GRECC (VA Medical) and Medicine, University of California Los Angeles, North Hills, CA 91343. Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor.Epidemiological studies show reduced risk of Alzheimer's disease among patients using non-steroidal inflammatory drugs (NSAID) indicating the role of inflammation in Alzheimer's disease. Studies have shown a chronic CNS inflammatory response associated with increased accumulation of amyloid peptide and activated microglia in Alzheimer's disease. Our previous studies showed that interaction of Abeta1-40 or fibrilar Abeta1-42 caused activation of nuclear transcription factor, early growth response-1 (Egr-1), which resulted in increased expression of cytokines (TNF-alpha and IL-1beta) and chemokines (MIP-1beta, MCP-1 and IL-8) in monocytes. We determined whether curcumin, a natural product known to have anti-inflammatory properties, suppressed Egr-1 activation and concomitant expression of cytochemokines. We show that curcumin (12.5-25 microm) suppresses the activation of Egr-1 DNA-binding activity in THP-1 monocytic cells. Curcumin abrogated Abeta1-40-induced expression of cytokines (TNF-alpha and IL-1beta) and chemokines (MIP-1beta, MCP-1 and IL-8) in both peripheral blood monocytes and THP-1 cells. We found that curcumin inhibited Abeta1-40-induced MAP kinase activation and the phosphorylation of ERK-1/2 and its downstream target Elk-1. We observed that curcumin inhibited Abeta1-40-induced expression of CCR5 but not of CCR2b in THP-1 cells. This involved abrogation of Egr-1 DNA binding in the promoter of CCR5 by curcumin as determined by: (i) electrophoretic mobility shift assay, (ii) transfection studies with truncated CCR5 gene promoter constructs, and (iii) chromatin immunoprecipitation analysis. Finally, curcumin inhibited chemotaxis of THP-1 monocytes in response to chemoattractant. The inhibition of Egr-1 by curcumin may represent a potential therapeutic approach to ameliorate the inflammation and progression of Alzheimer's disease. Giri RK, Rajagopal V, Kalra VK. Department of Biochemistry and Molecular Biology, University of Southern California, Keck School of Medicine, Los Angeles, California 90033, USA. Alzheimer's Research
|
Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disordersElevated homocysteine and low folate were associated with radiological markers of neuropathology. Since no patient had clinically deficient folate, it may be important to rethink what defines functionally significant micronutrient deficiency and explore what this means in different age- and health-status groups. Am J Geriatr
Psychiatry. 2004 Nov-Dec;12(6):631-8. Can cognitive deterioration associated with Down syndrome be reduced?By Thiel R, Fowkes SW. Center for Natural Health Research, Down Syndrome-Epilepsy Foundation, 2005;64(3):524-32. This paper suggests that essential nutrients such as folate, vitamin B6, vitamin C, vitamin E, selenium, and zinc, as well as alpha-lipoic acid and carnosine may be partially preventive. Continue Advertisement
Standardized Curcumin (Turmeric)Curcumin, the active constituent of the spice turmeric, is an antioxidant that may possess benefits for degenerative diseases. Curcumin has also shown a wide range of health-boosting properties, including support for inflammation relief and circulation. NSI’s standardized turmeric is a technically advanced herbal extract standardized to 95% curcuminoids, the highest concentration available. In several studies, curcumin has shown increasing potential as an anti-cancer agent. Curcumin has previously displayed success in protecting against the development of colonic tumors in laboratory animals treated with colon cancer-inducing agents. In a study published in the Journal of Carcinogenesis, curcumin appeared to induce cellular arrest when added to human colon cancer cells. Other studies show that curcumin's anti-cancer effects appear to be due to its ability to induce apoptosis, a predetermined death of cells, as well as to arrest the cell cycle. Other published studies show that curcumin effectively inhibits cancer cell growth in human skin cancer, lung cancer, and prostate cancer cells. Large randomized, double-blind, placebo-controlled studies need to be conducted in humans to prove benefits in cancer patients. Curcumin may hold anti-inflammatory properties, as studies have shown that it may benefit joint function, while reducing inflammation and pain. Curcumin has been shown to reduce inflammation by lowering histamine levels, while possibly increasing the production of natural cortisone by the adrenal glands. This antioxidant has been used in rheumatoid arthritis trials, and was shown to display some benefits for reducing inflammation and symptoms such as pain and stiffness. And in a study published in the International Journal of Clinical Pharmacology and Therapeutic Toxicology, curcumin was proven effective at easting post-surgical inflammation. In studies, curcumin has displayed other health benefits. It has been shown to aid circulation, as it may reduce platelets from clumping together, and may defend against atherosclerosis. Curcumin is also effective at shielding the liver from various toxic compounds. And one recent study showed that curcumin may have some benefit for cystic fibrosis. Bioperine®, derived from black pepper, is included to dramatically enhance absorption.
Nutraceutical ResearchA growing body of evidence shows how nutraceuticals may offer many advantages for the future of medicine.
Get Free Information about Herb, Vitamin and Drug InteractionsHealth Notes
is the leading provider of science-based information on healthy living.
Gathered from scientific studies published in over 550 peer-reviewed medical
and scientific journals. Visit
Health Notes for drug
interactions |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Legal Disclaimer:
Health statements on this page have not been evaluated by the FDA. The
health information on this site is for education purposes only. HeartSpring.net
assumes no responsibility in treatment or cure of any disease or illness. The information provided
on Heartspring.net is designed to support, not replace, the relationship that exists between a
patient/site visitor and his/her physician.
© 2008 Heartspring.net